$ATRA

Atara Biotherapeutics Inc

$ATRA

Atara Biotherapeutics Inc

Past 12mo:21mentions2voices

All voices6 calls since Jan 2026show all

Loading price chart…

About this stock

Over the past 12 months, $ATRA has been discussed by 2 distinct FinTwit voices across 21 mentions, with the first mention appearing on July 15, 2025. @jacobplieth dominates the conversation with 15 mentions, while @adamfeuerstein contributed 6 mentions. The discussions have centered on biotech-related developments, with recent activity focusing on regulatory matters surrounding Ebvallo and FDA considerations regarding study data submissions.

The most recent mentions from May 2026 reflect ongoing analysis of $ATRA's regulatory pathway. @jacobplieth's latest posts from May 7-8, 2026 examine the nuances of FDA communications regarding single-arm study approaches and the Allele dataset submission strategy, indicating continued scrutiny of the company's regulatory strategy and submission plans.

AI-generated from tracked posts · updated Jul 6, 2026

Related stocks

$ALLOAllogene Therapeutics

$ARVNArvinas

$BNTXBioNTech SE

$CELCCelcuity

Recent calls

6 calls

@jacobpliethMay 7, 2026 · 2:37 PM

There isn't a cat in hell's chance that $ATRA gets away with just resubmitting the Allele data.

Open on X

@adamfeuersteinMay 7, 2026 · 12:03 PM

An important update to the $ATRA / Pierre Fabre Ebvallo story just breaking: FDA to reconsider treatment for rare cancer after its surprise rejection https://t.co/8zQSb7q5jU

Open on X

@adamfeuersteinMar 12, 2026 · 12:11 PM

Pierre Fabre and $ATRA said FDA meeting to discuss the Ebvallo CRL has been scheduled. (Likely occuring within the next month.)

Open on X

@adamfeuersteinFeb 25, 2026 · 6:03 PM

New reporting from me on the FDA's rejection of Ebvallo, the cell therapy from $ATRA and Pierre Fabre intended for patients w/ a rare (and rapidly fatal) blood cancer. In late 2024/early 2025, FDA CBER staff examined the Ebvallo clinical data and recommended approval, pending resolution of manufacturing issues. But in January, CBER, now under Vinay Prasad, found the exact same Ebvallo clinical data deficient, and not approvable, even as the manufacturing issues were fixed. This is the inside story of a rare disease drug that was approvable, and then wasn't. It shows how the FDA's words of support for rare disease drugs are not matched by the agency's actions. Read the story here: https://t.co/tkpJQhIRM6

Open on X

@jacobpliethJan 12, 2026 · 2:13 PM

Statement from Pierre Fabre re $ATRA CRL https://t.co/V9fHHACgGC

Open on X

@adamfeuersteinJan 12, 2026 · 2:11 PM

Sunday: FDA tells cell and gene therapy developers not to worry about manufacturing. We got you, it's all good. We're here to help you. Marty Makary is walking through SFO shooting a video of himself to assure that THIS IS THE NEW FDA!!!! Monday: $ATRA cell therapy rejected. "... However, in a complete reversal of position by the FDA, the CRL claims that the single arm ALLELE trial, which was previously confirmed by the FDA as adequate to support the BLA filing, is no longer considered to be adequate to provide evidence of effectiveness for accelerated approval. Furthermore, the FDA stated that the trial’s interpretability is confounded due to trial study design, conduct, and analysis. The FDA’s new position is contrary to the FDA’s prior guidance to Atara, the FDA’s alignment with Atara on the clinical trial data set, and the acceptance of the trial design as a single arm study as relevant for this patient population at BLA submission. This prior alignment had been reached by Atara and the FDA through multiple, documented meetings held over the past five plus years." #JPM26

Open on X

Frequently asked

Who mentions $ATRA most on Surfaced?

@jacobplieth (Jacob Plieth) mentions $ATRA most — 15 mentions in the past 12 months.

When was $ATRA first mentioned on Surfaced?

The earliest tracked mention of $ATRA in the Surfaced archive was on Jul 15, 2025.

How many voices track $ATRA?

2 FinTwit voices have mentioned $ATRA 21 times in the past 12 months.

What kind of voices mention $ATRA most?

$ATRA is mentioned most by Biotech voices on Surfaced.